Personalized Health Association
Personalized Health Association is a federally registered 501(c)(4) non-profit founded in 2025 that advocates for regulatory modernization in personalized, regenerative, and precision medicine, uniting clinicians, scientists, entrepreneurs, and policymakers across telemedicine, compounding, diagnostics, nutraceuticals, AI, and peptide/stem cell verticals.
- Company typePrivate
- Founded2025
- HeadquartersOjai, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Personalized Health Association does
Personalized Health Association (PHA) is a federally registered 501(c)(4) education and advocacy organization incorporated in 2025 and headquartered at 1330 Foothill Rd, Ojai, California. The organization's stated mission is to advance personalized, regenerative, and precision medicine in the United States by modernizing outdated regulatory frameworks that PHA argues create barriers for patients and uncertainty for providers. PHA does not develop or sell products, services, or technology; instead, it operates as a national coalition platform uniting six verticals — telemedicine and digital health, 503A compounding pharmacies, diagnostics and biomarkers, nutraceuticals and supplements, AI and health data firms, and peptide and stem cell manufacturers — alongside clinicians, scientists, entrepreneurs, and policymakers.
PHA's go-to-market is policy advocacy and coalition facilitation rather than commercial distribution. Its marketing presence centers on its official website, PR Newswire-distributed press releases, and earned media coverage in outlets including Fox59 and the National Law Review. Revenue mechanics, where they exist, operate through membership dues and contributions collected via the website's structured "Join the Movement" intake form, which captures name, contact, company, and role data segmented across clinicians, practice owners, pharmacists, telehealth providers, policy advocates, industry vendors, and media.
PHA is led by President Jimmy St. Louis (also CEO of Agentis Longevity), with Founder/Director William (Bill) Moses (former KeVita Co-Founder/CEO, acquired by PepsiCo) and advisors Lee Rosebush, Esq. (BakerHostetler Partner, Outsourcing Facilities Association Founder), Emily Kaplan (Broken Science Initiative and MetFix Co-Founder), and Steve Bullock, Ph.D. (PerfecRx CEO). Between November 2025 and April 2026, PHA publicly launched, announced a national initiative to modernize stem cell and regenerative medicine policy, covered the December 2025 Texas Federal Court ruling in the Tirzepatide compounding dispute, and reported on the FDA's April 2026 update to the 503A bulk drug substances framework and peptide compound review.
Personalized Health Association firmographics
Firmographics- Name
- Personalized Health Association
- Legal name
- Personalized Health Association
- Website
- https://personalizedhealthassociation.org
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Personalized Health Association is a federally registered 501(c)(4) non-profit founded in 2025 that advocates for regulatory modernization in personalized, regenerative, and precision medicine, uniting clinicians, scientists, entrepreneurs, and policymakers across telemedicine, compounding, diagnostics, nutraceuticals, AI, and peptide/stem cell verticals.
- Ownership category
- akta.pro rank
Personalized Health Association industry classification
Industry- Product category
- Healthcare Policy Advocacy
- NAICS
- Business Associations (813910)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- KOL Engagement & Medical Education (Advisory Boards/CME Support) (HLAGALAM)
- akta.pro secondary industry
- Health Technology Assessment (HTA) & Reimbursement Policy Bodies (HLAJACAF)
Keywords
Where Personalized Health Association is headquartered
LocationHeadquarters
- HQ city
- Ojai
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Personalized Health Association business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Marketing channels4 records
Personalized Health Association product offering
Product offeringCore offering
The Personalized Health Association (PHA) is a federally registered 501(c)(4) education and advocacy organization that advances personalized, regenerative, and precision medicine through advocacy, education, and collaboration. PHA brings together clinicians, scientists, entrepreneurs, and policymakers to modernize outdated regulatory frameworks and expand patient access to personalized care. The organization does not sell commercial products or services; its activities are funded through membership dues and contributions.
Product overview
Personalized Health Association (PHA) is a federally registered 501(c)(4) education and advocacy organization rather than a product company. PHA advances personalized, regenerative, and precision medicine through advocacy, education, and collaboration. The organization does not offer commercial products or services; instead, it serves as a national platform uniting clinicians, scientists, entrepreneurs, and policymakers to advocate for policy modernization, expanded patient access, preserved physician judgment, and clear regulatory frameworks. Its focus areas include peptide therapies, regenerative medicine, compounding, and telemedicine.
Differentiator
Problem solved
Functional benefit
Companies that use Personalized Health Association
Customer profileSegments7 records
Ideal customer profiles6 records
Personalized Health Association technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Personalized Health Association partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
Personalized Health Association competitors and assessment
Company assessmentBroad incumbents
- Pharmaceutical Research and Manufacturers of America (PhRMA): Primary trade association for branded pharmaceutical manufacturers. Operates in adjacent regulatory territory around drug compounding, peptides, and personalized medicine, with vastly greater lobbying resources.
- American Pharmacists Association (APhA): Largest U.S. professional society of pharmacists, covering pharmacy practice, compounding, and regulatory policy. A more established, broader incumbent with overlapping interests in 503A framework reform.
- National Community Pharmacists Association (NCPA): Established trade association representing independent community pharmacies, including 503A compounders. Competes with PHA for influence over compounding policy but operates at significantly greater scale and broader scope.
- Biotechnology Innovation Organization (BIO): Largest U.S. biotech trade association covering cell therapy, gene therapy, and regenerative medicine. Represents the incumbent voice PHA must compete with on stem cell and regenerative medicine policy.
- Consumer Healthcare Products Association (CHPA): Trade association for OTC medicines, dietary supplements, and consumer health products. Comparable advocacy function in the nutraceutical and supplements regulatory space that PHA also targets.
Direct peers
- Alliance for Regenerative Medicine: International advocacy organization for regenerative medicine and cell/gene therapies. Directly comparable to PHA on the stem cell and regenerative medicine policy agenda PHA launched its December 2025 initiative around.
- American Telemedicine Association: Leading trade association advancing telehealth policy and remote care access. PHA explicitly lists Telemedicine & Digital Health Platforms as a primary member segment and cites telehealth regulatory modernization as a core use case.
- Outsourcing Facilities Association (OFA): Trade association for 503B compounding pharmacies, also founded and led by Lee Rosebush. Most direct peer — PHA shares leadership and the same pharmacy compounding/regulatory reform thesis, but operates as a 501(c)(4) covering a broader personalized medicine stack.
- Personalized Medicine Coalition: Education and advocacy organization promoting personalized medicine policy. Overlaps directly with PHA's mission on regulatory modernization and patient access, with a comparable membership-based, multi-stakeholder model.
Emerging players
- International Society for Stem Cell Research (ISSCR): Scientific society setting standards for stem cell research and clinical translation. Overlaps with PHA's regenerative medicine agenda but is research- rather than policy-led, providing scientific legitimacy PHA's advocacy can draw on.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Personalized Health Association social profiles
Digital presencePersonalized Health Association financial estimates
Financial estimateRevenue estimate
Valuation estimate
Personalized Health Association leadership team
Management profileNumber of profiles
Profiles5 records
Personalized Health Association funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Personalized Health Association M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Personalized Health Association
What does Personalized Health Association do?
The Personalized Health Association (PHA) is a federally registered 501(c)(4) education and advocacy organization that advances personalized, regenerative, and precision medicine through advocacy, education, and collaboration. PHA brings together clinicians, scientists, entrepreneurs, and policymakers to modernize outdated regulatory frameworks and expand patient access to personalized care. The organization does not sell commercial products or services; its activities are funded through membership dues and contributions.
Is Personalized Health Association a public or private company?
Personalized Health Association is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Personalized Health Association founded?
Personalized Health Association was founded in 2025. It employs 1 to 10 people.
Where is Personalized Health Association based?
Personalized Health Association is headquartered in Ojai, United States, in the North America region.
Who are Personalized Health Association's main competitors?
Broad incumbents on record are Pharmaceutical Research and Manufacturers of America (PhRMA), American Pharmacists Association (APhA), National Community Pharmacists Association (NCPA), Biotechnology Innovation Organization (BIO) and Consumer Healthcare Products Association (CHPA). Direct peers are Alliance for Regenerative Medicine, American Telemedicine Association, Outsourcing Facilities Association (OFA) and Personalized Medicine Coalition. International Society for Stem Cell Research (ISSCR) is listed as an emerging player.
Does Personalized Health Association have an API?
No public API is recorded for Personalized Health Association.
What industry is Personalized Health Association in?
Personalized Health Association's product category is Healthcare Policy Advocacy. Its primary akta.pro industry code is HLAGALAM, KOL Engagement & Medical Education (Advisory Boards/CME Support), with a secondary code of HLAJACAF, Health Technology Assessment (HTA) & Reimbursement Policy Bodies. Its NAICS code is 813910 and its SIC code is 8600.